Furthermore, patients with cancers positive for both antigen proteins, i.e., HSP70 and GPC3, tended to present a better overall survival (P = 0.08) and that tumor markers were reduced more often in patients with peptide-specific CTL induction for at least one of the two peptides (P = 0.031). This evidence concerns the gene GPC3 and cancer.